Daniel Gallagher is Chief Legal Officer at Mylan, a leading global pharmaceutical company. He has extensive public and private sector experience in regulatory matters, financial markets, and corporate legal affairs and governance. He is a member of the Board of Advisors of the Institute for Law and Economics at the University of Pennsylvania.
Prior to joining Mylan in 2017, Gallagher served as president of Patomak Global Partners, a financial services consulting firm. From Nov. 2011 to Oct. 2015, he served as a Commissioner of the U.S. Securities and Exchange Commission (SEC). As Commissioner, he called for reform on various corporate governance issues, advocated for conducting a comprehensive holistic review of equity market structure issues, and encouraged building the Commission's fixed income market expertise.
Gallagher also served on the staff of the SEC in several capacities, including as counsel to both SEC Commissioner Paul Atkins and Chairman Christopher Cox, working on matters involving the Division of Enforcement and the Division of Trading and Markets. Gallagher served as deputy director and co-acting director of the Division of Trading and Markets from 2008 to 2010, where he was on the front lines of the agency's response to the financial crisis, including representing the Commission in the Lehman Brothers liquidation.
Gallagher has significant private sector experience, having been a partner in the Washington, D.C. office of WilmerHale, and senior vice president and general counsel of Fiserv Securities, Inc.